KODK

Current Thesis

Dormant legacy-imaging shell (-1% to -5% YoY revenue since 2022) masking two embedded binary options: (1) the ~$530M KRIP pension reversion (plan terminated 2025-08-12, IRS sign-off expected H1 2026) and (2) the Rochester rare-earth/pharma-reagent pivot announced 2025-07. Q4 2025 (reported 2026-03-17) showed Advanced Materials & Chemicals +14% YoY to $19M — directional but still <8% of $260M quarterly rev. With Q1 2026 print scheduled ~2026-05-08 and a 3-trading-day pre-print blackout kicking in ~2026-05-05 close, the tradeable window is ~10 sessions. Narrative is NOT accelerating on KODK specifically; the flows on REE onshoring are absorbed by MP / USAR / Energy Fuels. Fresh entry here is a probe unless a named offtake 8-K or pension-receipt 8-K prints FIRST and the tape confirms with volume.

Bull Case

• Pension reversion crystallizing: KRIP terminated 2025-08-12; surplus est. ~$530M vs $477M total debt at Q4 2025 — 8-K confirming IRS sign-off = instant +20% balance-sheet re-rate (precedent: de-risking gaps on sub-$1B caps typically hold first 3 sessions).
• REE/pharma pivot has DoD tailwind: 2025-07-10 MP Materials DoD equity deal re-rated domestic REE complex (MP +80% since). KODK is the ONLY listed name with a permitted, operating chemical site outside MP/USAR/Energy Fuels — contract-win optionality is real.
• Q4 2025 AM&C slope: Chemicals rev +14% YoY to $19M on 2026-03-17 release — steepest slope in segment's history, management flagged "first meaningful offtake revenues 2H 2026."
• Squeeze mechanics: ~80M float, ~25% SI per 2026-03-31 NYSE short report, 4.2 days to cover. 2020-07 precedent: +1480% in 2 sessions on DFC headline — archetype-6 layer always live on ANY contract 8-K.
• Activist/spin optionality: proxy filed 2026-04-09 for May annual meeting; any board commentary on chemicals-segment spin or strategic review = incremental.
• Theme registry just flipped commodity-materials → ACCELERATING (2026-04-21) — if KODK catches the group bid, the REE leg re-prices off its dormant base.

Bear Case

• Core rotting: Print Systems rev -6% YoY Q4 2025; gross margin compressed to 16.8% from 19.1% YoY — no inflection visible and no roadmap given.
• Cash burn ex-pension: FY2025 operating cash flow -$31M vs +$22M FY2024. Pension is one-time; operating base is a melting ice cube.
• Execution slip risk: Zero signed offtake agreements as of 2026-03-17 call; "first revenues 2H 2026" language is verbatim from 2024-Q3 call — management has slipped twice.
• Dilution overhang: $100M ATM shelf filed 2025-11-XX. Any rip into $8+ likely met with issuance; caps upside absent monster squeeze.
• Sentiment cold: 2026-04-06 Benzinga flagged KODK among "tech stocks that may fall off a cliff in April." Zero retail velocity, no WSB/StockTwits 3d spike, no CNBC hits in 2 weeks. Narrative heat is elsewhere.
• KODK-specific REE narrative = DORMANT even as group theme accelerates; missing the bid after the peer group already ran ≈ late chaser.

Setup & Price Structure

No fresh price context supplied this run. Carrying reference frame from last analyzed (2026-04-21): range-bound $5.50–$7.20 since 2026-03-18 post-Q4 gap-down. 200-day SMA ~$6.40 is the pivot. Volume-profile demand node at $5.80 defended twice in April. Weekly 20-EMA ~$6.15. Downside trigger: daily close below $5.40 on >3M shares = 6-month base break → air pocket to $4.20 (2024 lows). Upside trigger: reclaim AND hold [entry redacted] on >2x ADV (>4M shares) = squeeze engaged, target [entry redacted] gap-fill then [entry redacted]+ on any headline assist. Chop between $5.80–$7.20 is untradeable. NO adding on weakness — $5.40 break = structurally broken, re-enter only on fresh higher-low setup above $6.40 200-SMA with volume.

Catalyst Calendar (next 30 days)

• ~2026-05-05 (close): Pre-earnings blackout begins (T-3 trading days). NO fresh entries after this bar.
• ~2026-05-08: Q1 2026 earnings — the binary. Street watching: (a) pension-reversion timeline confirmation, (b) named REE/pharma offtake partner, (c) AM&C segment revenue trajectory, (d) ATM usage in-quarter.
• May 2026 (date TBD, proxy filed 2026-04-09): Annual shareholder meeting. Watch for board commentary on chemicals-segment spin or strategic review — incremental optionality.
• H1 2026 (window): Pension-reversion 8-K — not date-certain but the fat-pitch catalyst. Any session.
• Rolling: REE/pharma offtake 8-K — unpredictable, any session. Tape-confirmation only trigger.

What Would Change Our Mind

• APPROVE probe (1–2% sizing) if: reclaim of [entry redacted] on >4M shares WITH a fresh named-offtake 8-K or pension-receipt 8-K in the tape. Options flow confirmation (C/P >2, unusual call sweeps on $7.5 / $10 strikes) required.
• APPROVE squeeze-leg (archetype 6, 1% CAP) if: SI refresh ≥28% AND price reclaims $7.50 AND borrow cost spikes — but trim aggressively on RSI>75, this is a day/swing not a hold.
• UPGRADE to MEDIUM if: commodity-materials theme stays ACCELERATING AND KODK participates (prints a higher-high above $7.20 on rel-strength vs XLB).
• SKIP / DEFER if: within 3 trading days of 2026-05-08 print (blackout), OR >5M ATM shares appear in 10-Q, OR Q1 release lacks pension timeline AND lacks named offtake (thesis broken, tape likely gaps to $5.40).
• Hard invalidation (exit / no re-entry): a daily close below the thesis-invalidation level on >3M shares.

Correlation Notes

• Primary peer cluster: MP, USAR, UUUU, LYSCF — REE onshoring basket. KODK correlation to MP has been 0.35–0.45 since 2025-07 pivot announcement (weak; KODK hasn't participated in last MP leg). Monitor MP tape as leading indicator of sector risk-on.
• Squeeze-cohort: archetype-6 comps BBIG, ATER, GME-style setups — KODK only joins the cohort if volume >3x ADV AND price clears $7.50. Otherwise it's a value-trap in squeeze cosplay.
• Macro: Small-cap value exposure (IWN correlation ~0.55) means regime matters — if SPY loses 20-week, KODK gets sold regardless of fundamentals.
• Dollar / rates: REE pivot story is DXY-inverse; weak-dollar regime helps the theme. TLT/DXY divergence is a weak tailwind.
• Not correlated to: AI/semi names, mega-cap tech. Don't confuse narrative heat elsewhere for KODK bid.